Targeting Mitochondrial Dysfunction and Oxidative Stress to Prevent the Neurodegeneration of Retinal Ganglion Cells.
ganglion cells
mitochondria
neurodegeneration
redox homeostasis
retina
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
17 Nov 2023
17 Nov 2023
Historique:
received:
16
10
2023
revised:
07
11
2023
accepted:
15
11
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
The imbalance of redox homeostasis contributes to neurodegeneration, including that related to the visual system. Mitochondria, essential in providing energy and responsible for several cell functions, are a significant source of reactive oxygen and/or nitrogen species, and they are, in turn, sensitive to free radical imbalance. Dysfunctional mitochondria are implicated in the development and progression of retinal pathologies and are directly involved in retinal neuronal degeneration. Retinal ganglion cells (RGCs) are higher energy consumers susceptible to mitochondrial dysfunctions that ultimately cause RGC loss. Proper redox balance and mitochondrial homeostasis are essential for maintaining healthy retinal conditions and inducing neuroprotection. In this respect, the antioxidant treatment approach is effective against neuronal oxidative damage and represents a challenge for retinal diseases. Here, we highlighted the latest findings about mitochondrial dysfunction in retinal pathologies linked to RGC degeneration and discussed redox-related strategies with potential neuroprotective properties.
Identifiants
pubmed: 38001864
pii: antiox12112011
doi: 10.3390/antiox12112011
pmc: PMC10669517
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : THE ITALIAN MINISTRY OF UNIVERSITY AND RESEARCH (MUR)
ID : PRIN2020
Organisme : Rome Technopole - Innovation Ecosystem PNRR
ID : Rome Technopole - Innovation Ecosystem PNRR
Références
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):578-87
pubmed: 12750875
Theranostics. 2019 Apr 13;9(8):2395-2410
pubmed: 31149051
Prog Retin Eye Res. 2020 Nov;79:100858
pubmed: 32298788
Cell Death Differ. 2020 Aug;27(8):2383-2401
pubmed: 32042098
Antioxidants (Basel). 2020 Apr 23;9(4):
pubmed: 32340220
Antioxidants (Basel). 2021 Sep 28;10(10):
pubmed: 34679672
Exp Cell Res. 2018 Feb 15;363(2):299-309
pubmed: 29366807
Pharmacol Res. 2021 Apr;166:105488
pubmed: 33582248
Hum Mol Genet. 2020 Jun 3;29(9):1454-1464
pubmed: 32277753
Redox Biol. 2020 Oct;37:101799
pubmed: 33248932
Science. 2002 Feb 8;295(5557):1077-9
pubmed: 11834836
J Clin Med. 2020 Apr 24;9(4):
pubmed: 32344515
Neural Regen Res. 2020 Jul;15(7):1253-1254
pubmed: 31960808
Dis Model Mech. 2018 Jul 30;11(7):
pubmed: 29929962
BMC Ophthalmol. 2023 Mar 24;23(1):118
pubmed: 36964505
Antioxidants (Basel). 2021 Jul 27;10(8):
pubmed: 34439445
Trends Mol Med. 2020 Jan;26(1):105-118
pubmed: 31771932
J Clin Med. 2019 Sep 01;8(9):
pubmed: 31480638
Mol Neurodegener. 2018 Oct 17;13(1):56
pubmed: 30333037
Front Neurosci. 2023 Mar 13;17:1171235
pubmed: 36992855
Front Cell Neurosci. 2017 Dec 15;11:410
pubmed: 29326555
Front Neurosci. 2020 Jul 31;14:758
pubmed: 32848548
Biomedicines. 2023 May 23;11(6):
pubmed: 37371607
J Cell Mol Med. 2020 May;24(9):4892-4899
pubmed: 32279443
Int J Mol Sci. 2021 Dec 25;23(1):
pubmed: 35008635
Cells. 2023 Feb 11;12(4):
pubmed: 36831253
Aging (Albany NY). 2019 May 19;11(10):3117-3137
pubmed: 31105084
Clin Exp Pharmacol Physiol. 2021 Jul;48(7):943-953
pubmed: 33752254
Biomed Pharmacother. 2023 Oct;166:115298
pubmed: 37597318
Pharmaceutics. 2023 Jan 18;15(2):
pubmed: 36839646
J Exp Med. 2008 May 12;205(5):1227-42
pubmed: 18458112
Antioxidants (Basel). 2022 Mar 05;11(3):
pubmed: 35326154
Int J Mol Sci. 2019 May 21;20(10):
pubmed: 31117258
Metabolites. 2023 Jan 27;13(2):
pubmed: 36837806
Cells. 2021 Jun 02;10(6):
pubmed: 34199494
Antioxidants (Basel). 2023 Mar 07;12(3):
pubmed: 36978905
ACS Nano. 2023 Jan 10;17(1):168-183
pubmed: 36524981
Cell Death Dis. 2020 Apr 20;11(4):254
pubmed: 32312949
Antioxidants (Basel). 2021 Apr 28;10(5):
pubmed: 33924878
Cell Mol Life Sci. 2021 Feb;78(4):1615-1636
pubmed: 32749504
Int J Mol Sci. 2020 Feb 29;21(5):
pubmed: 32121432
Exp Eye Res. 2021 Mar;204:108449
pubmed: 33465395
Redox Biol. 2019 Jun;24:101199
pubmed: 31026769
Cells. 2023 Jun 03;12(11):
pubmed: 37296658
Mol Cell Biol. 2014 Mar;34(5):807-19
pubmed: 24344202
Ophthalmol Retina. 2022 Jan;6(1):65-79
pubmed: 34257060
Pharmacol Res. 2022 Nov;185:106516
pubmed: 36272637
Cells. 2023 Jan 12;12(2):
pubmed: 36672234
Adv Exp Med Biol. 2019;1185:513-517
pubmed: 31884663
Mitochondrion. 2023 Jul;71:83-92
pubmed: 37269968
Neuron. 2017 Mar 8;93(5):1015-1034
pubmed: 28279350
Front Mol Neurosci. 2021 Apr 15;14:656000
pubmed: 33935647
Redox Biol. 2023 Jun;62:102687
pubmed: 36989574
Antioxidants (Basel). 2021 Dec 05;10(12):
pubmed: 34943051
Neurosci Lett. 2019 Aug 24;708:134337
pubmed: 31220522
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165686
pubmed: 31953215
Commun Biol. 2023 Feb 24;6(1):218
pubmed: 36828933
Pharmacol Res. 2018 Feb;128:167-178
pubmed: 28970178
Naunyn Schmiedebergs Arch Pharmacol. 2004 Aug;370(2):91-8
pubmed: 15309377
Front Neurosci. 2021 Jun 29;15:719717
pubmed: 34267626
Redox Biol. 2020 Oct;37:101703
pubmed: 32896719